{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T01:58:09Z","timestamp":1775008689779,"version":"3.50.1"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T00:00:00Z","timestamp":1560556800000},"content-version":"am","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01NS103931"],"award-info":[{"award-number":["1R01NS103931"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR062207"],"award-info":[{"award-number":["R01AR062207"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR061484"],"award-info":[{"award-number":["R01AR061484"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201606240021"],"award-info":[{"award-number":["201606240021"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-16-1-0482"],"award-info":[{"award-number":["W81XWH-16-1-0482"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.cytogfr.2018.04.003","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T12:49:57Z","timestamp":1523450997000},"page":"65-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Molecular regulations and therapeutic targets of Gaucher disease"],"prefix":"10.1016","volume":"41","author":[{"given":"Yuehong","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neetu","family":"Sud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aubryanna","family":"Hettinghouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan-ju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2018.04.003_bib0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neuint.2015.12.004","article-title":"Advances in GBA-associated Parkinson\u2019s disease\u2014pathology, presentation and therapies","volume":"93","author":"Barkhuizen","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bcmd.2005.07.005","article-title":"Hematologically important mutations: Gaucher disease","volume":"35","author":"Beutler","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0950-3536(97)80032-7","article-title":"Gaucher\u2019s disease: molecular, genetic and enzymological aspects","volume":"10","author":"Grabowski","year":"1997","journal-title":"Baillieres Clin. Haematol."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0020","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1086\/302925","article-title":"Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease","volume":"66","author":"Koprivica","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0025","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bcmd.2016.10.001","article-title":"Liver involvement in Gaucher disease - review and clinical approach","volume":"68","author":"Adar","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0030","first-page":"299","article-title":"Gaucher disease: clinical profile and therapeutic developments","volume":"4","author":"Cox","year":"2010","journal-title":"Biologics"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejim.2013.09.006","article-title":"Gaucher disease: a diagnostic challenge for internists","volume":"25","author":"Cassinerio","year":"2014","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0040","first-page":"35","article-title":"Glucosylceramide lipidosis\u2013Gaucher disease","volume":"vol. 36","author":"Beutler","year":"2001"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0045","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ajmg.a.20117","article-title":"Perinatal-lethal Gaucher disease","volume":"120a","author":"Mignot","year":"2003","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0055","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","article-title":"ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity","volume":"14","author":"Ron","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0060","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1096\/fj.15-271148","article-title":"Role of LIMP-2 in the intracellular trafficking of beta-glucosidase in different human cellular models","volume":"29","author":"Malini","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0065","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00018-005-5437-0","article-title":"Therapeutic strategies to ameliorate lysosomal storage disorders\u2014a focus on Gaucher disease","volume":"63","author":"Sawkar","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0070","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2008.06.037","article-title":"Chemical and biological approaches synergize to ameliorate protein-folding diseases","volume":"134","author":"Mu","year":"2008","journal-title":"Cell"},{"issue":"February","key":"10.1016\/j.cytogfr.2018.04.003_bib0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bcmd.2016.10.014","article-title":"Treatment patterns from 647 patients with Gaucher disease: an analysis from the gaucher outcome survey","volume":"68","author":"Deegan","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0080","doi-asserted-by":"crossref","first-page":"e28714","DOI":"10.4161\/psb.28714","article-title":"Alteration of the proteostasis network of plant cells promotes the post-endoplasmic reticulum trafficking of recombinant mutant (L444P) human beta-glucocerebrosidase","volume":"9","author":"Babajani","year":"2014","journal-title":"Plant Signal. Behav."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0085","doi-asserted-by":"crossref","first-page":"43454","DOI":"10.1074\/jbc.M111.274332","article-title":"Inhibition of endoplasmic reticulum-associated degradation rescues native folding in loss of function protein misfolding diseases","volume":"286","author":"Wang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2352-4642(17)30087-1","article-title":"Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNS","volume":"2","author":"Giugliani","year":"2018","journal-title":"Lancet Child. Adolesc. Health"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0095","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bcmd.2016.10.014","article-title":"Treatment patterns from 647 patients with Gaucher disease: an analysis from the Gaucher outcome survey","volume":"68","author":"Deegan","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrd.2017.214","article-title":"Emptying the stores: lysosomal diseases and therapeutic strategies","volume":"17","author":"Platt","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/(SICI)1096-9896(199908)188:4<407::AID-PATH377>3.0.CO;2-Z","article-title":"Intracellular transport of acid \u03b2-glucosidase and lysosome-associated membrane proteins is affected in Gaucher\u2019s disease (G202R mutation)","volume":"188","author":"Zimmer","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0110","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/oxfordjournals.jbchem.a021820","article-title":"Identification and characterization of a major lysosomal membrane glycoprotein, LGP85\/LIMP II in mouse liver","volume":"122","author":"Tabuchi","year":"1997","journal-title":"J. Biochem."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0115","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/tra.12313","article-title":"Mannose 6-phosphate-independent lysosomal sorting of LIMP-2","volume":"16","author":"Blanz","year":"2015","journal-title":"Traffic"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0120","doi-asserted-by":"crossref","first-page":"30063","DOI":"10.1074\/jbc.M114.593616","article-title":"The LIMP-2\/SCARB2 binding motif on acid beta-glucosidase: basic and applied implications for Gaucher disease and associated neurodegenerative diseases","volume":"289","author":"Liou","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.chembiol.2012.11.014","article-title":"FKBP10 depletion enhances glucocerebrosidase proteostasis in Gaucher disease fibroblasts","volume":"20","author":"Ong","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0130","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1091\/mbc.e11-06-0553","article-title":"Two phosphatidylinositol 4-kinases control lysosomal delivery of the Gaucher disease enzyme, beta-glucocerebrosidase","volume":"23","author":"Jovic","year":"2012","journal-title":"Mol. Biol Cell."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0135","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bbamcr.2008.09.020","article-title":"Principles of lysosomal membrane degradation: cellular topology and biochemistry of lysosomal lipid degradation","volume":"1793","author":"Schulze","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0140","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/jnr.22371","article-title":"A mutation in the saposin C domain of the sphingolipid activator protein (prosaposin) gene causes neurodegenerative disease in mice","volume":"88","author":"Yoneshige","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0145","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1194\/jlr.M073510","article-title":"Lipids regulate the hydrolysis of membrane bound glucosylceramide by lysosomal beta-glucocerebrosidase","volume":"58","author":"Abdul-Hammed","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0150","doi-asserted-by":"crossref","first-page":"16746","DOI":"10.1016\/S0021-9258(19)89454-1","article-title":"Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase","volume":"269","author":"Qi","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0155","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1399-0004.2007.00899.x","article-title":"Non-neuronopathic Gaucher disease due to saposin C deficiency","volume":"72","author":"Tylki-Szymanska","year":"2007","journal-title":"Clin. Genet."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0160","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/prot.21554","article-title":"An evolutionary and structure-based docking model for glucocerebrosidase-saposin C and glucocerebrosidase-substrate interactions \u2013 relevance for Gaucher disease","volume":"70","author":"Atrian","year":"2008","journal-title":"Proteins"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0165","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1093\/hmg\/ddu299","article-title":"Gaucher disease due to saposin C deficiency is an inherited lysosomal disease caused by rapidly degraded mutant proteins","volume":"23","author":"Motta","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0170","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4161\/auto.7.1.13884","article-title":"Autophagy in Gaucher disease due to saposin C deficiency","volume":"7","author":"Tatti","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0175","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/hmg\/ddq204","article-title":"Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting","volume":"19","author":"Vaccaro","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0180","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1093\/hmg\/dds367","article-title":"Reduced cathepsins B and D cause impaired autophagic degradation that can be almost completely restored by overexpression of these two proteases in Sap C-deficient fibroblasts","volume":"21","author":"Tatti","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0185","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1093\/hmg\/ddv153","article-title":"BCM-95 and (2-hydroxypropyl)-beta-cyclodextrin reverse autophagy dysfunction and deplete stored lipids in Sap C-deficient fibroblasts","volume":"24","author":"Tatti","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0190","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/hmg\/ddp531","article-title":"Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouse","volume":"19","author":"Sun","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0195","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1194\/jlr.M500202-JLR200","article-title":"Gaucher disease mouse models: point mutations at the acid beta-glucosidase locus combined with low-level prosaposin expression lead to disease variants","volume":"46","author":"Sun","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0200","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/hmg\/ddp580","article-title":"Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits","volume":"19","author":"Sun","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0205","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1073\/pnas.68.11.2810","article-title":"Gaucher\u2019s disease: deficiency of \u2018acid\u2019-glucosidase and reconstitution of enzyme activity in vitro","volume":"68","author":"Ho","year":"1971","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0210","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.clinbiochem.2015.06.004","article-title":"The effects of chemically synthesized saposin C on glucosylceramide-beta-glucosidase","volume":"48","author":"Yoneshige","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0215","doi-asserted-by":"crossref","first-page":"31918","DOI":"10.1074\/jbc.M302752200","article-title":"Saposin C is required for normal resistance of acid beta-glucosidase to proteolytic degradation","volume":"278","author":"Sun","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"Feb. (2)","key":"10.1016\/j.cytogfr.2018.04.003_bib0220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1189\/jlb.0812429","article-title":"Insights into the role of progranulin in immunity, infection, and inflammation","volume":"93","author":"Jian","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0225","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1189\/jlb.0812429","article-title":"Insights into the role of progranulin in immunity, infection, and inflammation","volume":"93","author":"Jian","year":"2013","journal-title":"J. Leukoc. Biol."},{"issue":"January","key":"10.1016\/j.cytogfr.2018.04.003_bib0230","first-page":"48","article-title":"Progranulin: a key player in autoimmune diseases","volume":"101","author":"Jian","year":"2016","journal-title":"Cytokine."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0235","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1016\/j.febslet.2011.04.065","article-title":"Progranulin: a promising therapeutic target for rheumatoid arthritis","volume":"585","author":"Liu","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0240","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pharmthera.2011.10.003","article-title":"Progranulin: a growth factor, a novel TNFR ligand and a drug target","volume":"133","author":"Liu","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0245","doi-asserted-by":"crossref","DOI":"10.1111\/nyas.13191","article-title":"The role of progranulin in arthritis","author":"Wei","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0250","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s00109-003-0474-3","article-title":"Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis","volume":"81","author":"He","year":"2003","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0255","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s12031-011-9569-4","article-title":"Structure, function, and mechanism of progranulin; The brain and beyond","volume":"45","author":"Toh","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0260","doi-asserted-by":"crossref","first-page":"11347","DOI":"10.1074\/jbc.M608744200","article-title":"Cartilage oligomeric matrix protein associates with granulin-epithelin precursor (GEP) and potentiates GEP-stimulated chondrocyte proliferation","volume":"282","author":"Xu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0265","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1096\/fj.09-144659","article-title":"Granulin epithelin precursor: a bone morphogenic protein 2-inducible growth factor that activates Erk1\/2 signaling and JunB transcription factor in chondrogenesis","volume":"24","author":"Feng","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0270","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.1174447","article-title":"A gene network regulating lysosomal biogenesis and function","volume":"325","author":"Sardiello","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0275","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.1204592","article-title":"TFEB links autophagy to lysosomal biogenesis","volume":"332","author":"Settembre","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0280","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrn.2017.36","article-title":"Progranulin, lysosomal regulation and neurodegenerative disease","volume":"18","author":"Kao","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0285","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s40478-014-0078-x","article-title":"Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice","volume":"2","author":"Tanaka","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0290","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ajhg.2012.04.021","article-title":"Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage","volume":"90","author":"Smith","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0295","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-014-1262-6","article-title":"Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis","author":"Gotzl","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0300","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ebiom.2016.08.004","article-title":"Association between progranulin and Gaucher disease","volume":"11","author":"Jian","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0305","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ebiom.2016.10.010","article-title":"Progranulin recruits HSP70 to beta-glucocerebrosidase and Is therapeutic against Gaucher disease","volume":"13","author":"Jian","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0310","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.imbio.2015.11.014","article-title":"Chitinases and immunity: ancestral molecules with new functions","volume":"221","author":"Rosa","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0315","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ebiom.2018.01.022","article-title":"Chitinase-3-like protein 1: a progranulin downstream molecule and potential biomarker for Gaucher disease","volume":"28","author":"Jian","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0320","doi-asserted-by":"crossref","first-page":"21665","DOI":"10.1073\/pnas.1014376107","article-title":"Decreased glucocerebrosidase activity in Gaucher disease parallels quantitative enzyme loss due to abnormal interaction with TCP1 and c-Cbl","volume":"107","author":"Lu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0325","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1128\/MCB.23.16.5790-5802.2003","article-title":"HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation","volume":"23","author":"Parcellier","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0330","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1073\/pnas.1424288112","article-title":"Mutant glucocerebrosidase in Gaucher disease recruits Hsp27 to the Hsp90 chaperone complex for proteasomal degradation","volume":"112","author":"Yang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0335","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature14884","article-title":"Crucial HSP70 co-chaperone complex unlocks metazoan protein disaggregation","volume":"524","author":"Nillegoda","year":"2015","journal-title":"Nature"},{"issue":"Aug. (15)","key":"10.1016\/j.cytogfr.2018.04.003_bib0340","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1093\/hmg\/ddx162","article-title":"Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo","volume":"26","author":"Beel","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0345","doi-asserted-by":"crossref","first-page":"21200","DOI":"10.1073\/pnas.1119181109","article-title":"Histone deacetylase inhibitors prevent the degradation and restore the activity of glucocerebrosidase in Gaucher disease","volume":"108","author":"Lu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0350","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1073\/pnas.1221046110","article-title":"Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones","volume":"110","author":"Yang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0355","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bcmd.2010.10.012","article-title":"Characterization of the ERAD process of the L444P mutant glucocerebrosidase variant","volume":"46","author":"Bendikov-Bar","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0360","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1073\/pnas.1321341111","article-title":"Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones","volume":"111","author":"Yang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0365","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.chembiol.2014.06.008","article-title":"ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher\u2019s disease","volume":"21","author":"Tan","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0370","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI0214530","article-title":"Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage","volume":"109","author":"Mizukami","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0375","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/brain\/aws095","article-title":"Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher\u2019s disease","volume":"135","author":"Vitner","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0380","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/hmg\/ddr019","article-title":"Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease","volume":"20","author":"Farfel-Becker","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0385","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0925-4439(96)00056-7","article-title":"Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease","volume":"1317","author":"Michelakakis","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0390","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cyto.2005.03.006","article-title":"TNF-alpha levels and TNF-alpha gene polymorphism in type I Gaucher disease","volume":"31","author":"Altarescu","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0395","first-page":"205","article-title":"Cytokines in Gaucher\u2019s disease","volume":"10","author":"Barak","year":"1999","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0400","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF01870457","article-title":"Tumor necrosis factor inhibits K++ current expression in cultured oligodendrocytes","volume":"124","author":"Soliven","year":"1991","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0405","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.410230405","article-title":"Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro","volume":"23","author":"Selmaj","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0410","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1096\/fj.201601134R","article-title":"Foxo4- and Stat3-dependent IL-10 production by progranulin in regulatory T cells restrains inflammatory arthritis","volume":"31","author":"Fu","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0415","doi-asserted-by":"crossref","first-page":"e92743","DOI":"10.1371\/journal.pone.0092743","article-title":"Progranulin-derived atsttrin directly binds to TNFRSF25 (DR3) and inhibits TNF-like ligand 1A (TL1A) activity","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0420","doi-asserted-by":"crossref","first-page":"21115","DOI":"10.1038\/srep21115","article-title":"Progranulin inhibits expression and release of chemokines CXCL9 and CXCL10 in a TNFR1 dependent manner","volume":"6","author":"Mundra","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0425","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1126\/science.1199214","article-title":"The growth factor progranulin binds to TNF receptors and Is therapeutic against inflammatory arthritis in mice","volume":"332","author":"Tang","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0430","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-1-4939-0669-7_14","article-title":"A solid-phase assay for studying direct binding of progranulin to TNFR and progranulin antagonism of TNF\/TNFR interactions","volume":"1155","author":"Tian","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0435","doi-asserted-by":"crossref","first-page":"e112110","DOI":"10.1371\/journal.pone.0112110","article-title":"Progranulin facilitates conversion and function of regulatory T cells under inflammatory conditions","volume":"9","author":"Wei","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0440","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/art.39816","article-title":"Review: novel insights into tumor necrosis factor receptor, death receptor 3, and progranulin pathways in arthritis and bone remodeling","volume":"68","author":"Williams","year":"2016","journal-title":"Arthr. Rheumatol."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0445","first-page":"e50924","article-title":"Establishment of a surgically-induced model in mice to investigate the protective role of progranulin in osteoarthritis","author":"Zhao","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0450","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1136\/annrheumdis-2014-205779","article-title":"Progranulin protects against osteoarthritis through interacting with TNF-alpha and beta-catenin signalling","volume":"74","author":"Zhao","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0455","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1016\/j.biomaterials.2013.05.030","article-title":"The promotion of bone healing by progranulin, a downstream molecule of BMP-2, through interacting with TNF\/TNFR signaling","volume":"34","author":"Zhao","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0460","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.1038\/srep09102","article-title":"Progranulin knockout accelerates intervertebral disc degeneration in aging mice","volume":"5","author":"Zhao","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0465","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.febslet.2013.04.037","article-title":"Progranulin deficiency exaggerates, whereas progranulin-derived Atsttrin attenuates, severity of dermatitis in mice","volume":"587","author":"Zhao","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0470","doi-asserted-by":"crossref","first-page":"20909","DOI":"10.1038\/srep20909","article-title":"Progranulin suppresses titanium particle induced inflammatory osteolysis by targeting TNFalpha signaling","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0475","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.gendis.2017.05.001","article-title":"Progranulin acts as a shared chaperone and regulates multiple lysosomal enzymes","volume":"4","author":"Jian","year":"2017","journal-title":"Genes Dis."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0480","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3346\/jkms.2006.21.4.733","article-title":"Upregulation of proinflammatory cytokines in the fetal brain of the Gaucher mouse","volume":"21","author":"Hong","year":"2006","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0485","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/bcmd.1997.0137","article-title":"Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease","volume":"23","author":"Hollak","year":"1997","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0490","doi-asserted-by":"crossref","first-page":"e0136633","DOI":"10.1371\/journal.pone.0136633","article-title":"Activation of p38 mitogen-activated protein kinase in Gaucher\u2019s disease","volume":"10","author":"Kitatani","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0495","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/qjmed\/90.1.19","article-title":"Pro-inflammatory cytokines and the pathogenesis of Gaucher\u2019s disease: increased release of interleukin-6 and interleukin-10","volume":"90","author":"Allen","year":"1997","journal-title":"QJM"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0500","doi-asserted-by":"crossref","first-page":"12979","DOI":"10.1074\/jbc.M809500200","article-title":"Acid beta-glucosidase 1 counteracts p38delta-dependent induction of interleukin-6: possible role for ceramide as an anti-inflammatory lipid","volume":"284","author":"Kitatani","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0505","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nri3133","article-title":"Immunomodulatory functions of type I interferons","volume":"12","author":"Gonzalez-Navajas","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0510","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12974-016-0570-2","article-title":"Induction of the type I interferon response in neurological forms of Gaucher disease","volume":"13","author":"Vitner","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0515","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm.3449","article-title":"RIPK3 as a potential therapeutic target for Gaucher\u2019s disease","volume":"20","author":"Vitner","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0520","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1074\/mcp.M600303-MCP200","article-title":"Analysis and quantification of diagnostic serum markers and protein signatures for Gaucher disease","volume":"6","author":"Vissers","year":"2007","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0525","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1089\/ars.2015.6307","article-title":"Sustained systemic glucocerebrosidase inhibition induces brain alpha-synuclein aggregation, microglia and complement C1q activation in mice","volume":"23","author":"Rocha","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0530","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature21368","article-title":"Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease","volume":"543","author":"Pandey","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2018.02.006","article-title":"An unexpected player in Gaucher disease: the multiple roles of complement in disease development","author":"Pandey","year":"2018","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0540","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/2051-5960-1-36","article-title":"Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain","volume":"1","author":"Busch","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0545","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00401-016-1610-9","article-title":"What we know about TMEM106B in neurodegeneration","volume":"132","author":"Nicholson","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0550","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/ng.536","article-title":"Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions","volume":"42","author":"Van Deerlin","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0555","doi-asserted-by":"crossref","first-page":"11213","DOI":"10.1523\/JNEUROSCI.0521-12.2012","article-title":"TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132\/212 cluster and affects progranulin pathways","volume":"32","author":"Chen-Plotkin","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0560","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.mcn.2014.07.006","article-title":"Lysosome size, motility and stress response regulated by fronto-temporal dementia modifier TMEM106B","volume":"61","author":"Stagi","year":"2014","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2017.06.026","article-title":"Loss of TMEM106B ameliorates lysosomal and frontotemporal dementia-related phenotypes in progranulin-deficient mice","volume":"95","author":"Klein","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0570","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson\u2019s syndrome in type I Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"QJM"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0575","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ymgme.2003.11.004","article-title":"Glucocerebrosidase mutations in subjects with parkinsonism","volume":"81","author":"Lwin","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-017-0233-5","article-title":"alpha-synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism","volume":"13","author":"Yun","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0585","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ymgme.2010.12.014","article-title":"Accumulation and distribution of alpha-synuclein and ubiquitin in the CNS of Gaucher disease mouse models","volume":"102","author":"Xu","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0590","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0595","first-page":"7693","article-title":"Activation of beta-glucocerebrosidase reduces pathological alpha-synuclein and restores lysosomal function in Parkinson's","volume":"36","author":"Mazzulli","year":"2016","journal-title":"Patient Midbrain Neurons"},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0600","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.nbd.2015.09.009","article-title":"Glucocerebrosidase gene therapy prevents alpha-synucleinopathy of midbrain dopamine neurons","volume":"82","author":"Rocha","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0605","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.1523\/JNEUROSCI.0636-16.2016","article-title":"A new glucocerebrosidase chaperone reduces alpha-synuclein and glycolipid levels in iPSC-derived dopaminergic neurons from patients with Gaucher disease and Parkinsonism","volume":"36","author":"Aflaki","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0610","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/mds.26802","article-title":"Lysosomal trafficking defects link Parkinson\u2019s disease with Gaucher\u2019s disease","volume":"31","author":"Wong","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0615","doi-asserted-by":"crossref","first-page":"21673","DOI":"10.1074\/jbc.274.31.21673","article-title":"Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons","volume":"274","author":"Korkotian","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0620","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nbd.2004.09.004","article-title":"Enhanced calcium release in the acute neuronopathic form of Gaucher disease","volume":"18","author":"Pelled","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0625","first-page":"5126","article-title":"Modulating ryanodine receptors with dantrolene attenuates neuronopathic phenotype in Gaucher disease mice","volume":"25","author":"Liou","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0630","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.chembiol.2011.04.008","article-title":"Lacidipine remodels protein folding and Ca 2+ homeostasis in Gaucher's disease fibroblasts: a mechanism to rescue mutant glucocerebrosidase","volume":"18","author":"Wang","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0635","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00277-015-2354-7","article-title":"Osteopontin: a potential biomarker of Gaucher disease","volume":"94","author":"Vairo","year":"2015","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0640","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bcmd.2016.12.002","article-title":"Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease","volume":"68","author":"Murugesan","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0645","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1515\/CCLM.2002.010","article-title":"Relationships between serum markers of monocyte\/macrophage activation in type 1 Gaucher\u2019s disease","volume":"40","author":"Casal","year":"2002","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cytogfr.2018.04.003_bib0650","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/10245332.2016.1144336","article-title":"Evaluation of neopterin as a biomarker for the monitoring of Gaucher disease patients","volume":"21","author":"Drugan","year":"2016","journal-title":"Hematology"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610118300534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610118300534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:55:07Z","timestamp":1761216907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610118300534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":130,"alternative-id":["S1359610118300534"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2018.04.003","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular regulations and therapeutic targets of Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2018.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}